Stocktoria

ORASURE TECHNOLOGIES INC OSUR

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1986-11-17

ORASURE TECHNOLOGIES INC financials (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Revenue$115.0M$185.8M$405.5M$387.5M$233.7M
Gross profit$48.2M$79.4M$171.7M$148.4M$117.6M
R&D expense$42.5M$26.0M$33.7M$36.2M$34.2M
Operating income-$72.0M-$28.2M$32.7M-$22.2M-$10.2M
Income tax$1.8M$1.8M$2.6M$1.5M$13.7M
Net income-$68.7M-$19.5M$53.7M-$17.1M-$23.0M
EPS (diluted)$-0.94$-0.26$0.72$-0.24$-0.32
Operating cash flow-$49.0M$27.4M$141.6M-$47.2M-$35.4M
Free cash flow-$53.2M$23.6M$135.8M-$54.0M-$57.3M
Cash & equivalents$199.3M$267.8M$290.4M$84.0M$116.8M
Inventory$31.1M$34.2M$47.6M$95.7M$53.1M
Total assets$403.2M$479.7M$482.8M$444.2M$461.0M
Total liabilities$62.3M$69.3M$52.2M$79.8M$80.5M
Shareholders' equity$340.8M$410.3M$430.7M$364.4M$380.5M

Source: SEC EDGAR filings · CIK 0001116463 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.